Reducing antimicrobial resistance in the community by restricting prescribing: Can it be done?

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 2, 2009, Pages 179-182

  Enne, Virve I ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Biological fitness; Clonal population; Co selection; Escherichia coli; Streptococcus

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLONE DERIVATIVE; SULFONAMIDE; TRIMETHOPRIM;

ANTHRAX; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; COMMUNITY CARE; DRUG USE; ESCHERICHIA COLI; FINLAND; HOSPITAL POLICY; ICELAND; NONHUMAN; PHENOTYPE; PLASMID; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; WARD;

EID: 77950201484     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp443     Document Type: Article

References (34)

1. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999; 2: 489-93.
2. Climo MW, Israel DS, Wong ES et al. Hospital-wide restriction of clindamycin: effect on incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 1998; 128: 989-95.
3. Bradley SJ, Wilson ALT, Allen MC et al. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999; 43: 261-6.
4. van den Bogaard AE, Bruisma N, Stobberingh EE. The effect of banning avoparcin on VRE carriage in The Netherlands. J Antimicrob Chemother 2000; 46: 146-8.
5. Aarestrup FM, Seyfarth AM, Emborg H-D et al. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 2001; 45: 2054-9.
6. Heuer OE, Pedersen K, Jensen LB et al. Persistence of vancomycin-resistant enterococci (VRE) in broiler houses after the avoparcin ban. Microb Drug Res 2002; 8: 355-61.
7. Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280: 1233-7.
8. Sundqvist M, Geli P, Andersson DI et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 2009; 65: 350-60.
9. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Eng J Med 1997; 337: 441-6.
10. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Nat Acad Sci USA 1999; 96: 1152-6.
11. Enne VI, Livermore DM, Stephens P et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325-8.
12. Chiew YF, Yeo SF, Hall LM et al. Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae. J Antimicrob Chemother 1998; 41: 247-51.
13. Gottesman BS, Carmeli Y, Shitrit P et al. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49: 869-75.
14. Kataja J, Huovinen P, Muotiala A et al. Clonal spread of group A Streptococcus with the new type of erythromycin resistance. J Infect Dis 1998; 177: 786-9.
15. Kataja J, Huovinen P, Skurnik M et al. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob Agents Chemother 1999; 43: 48-52.
16. Soares S, Kristinsson KG, Musser JM et al. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63.
17. Bean DC, Livermore DM, Papa I et al. Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother 2005; 56: 962-4.
18. Johnsen P, Townsend JP, Bohn T et al. Factors affecting the reversal of antimicrobial-drug resistance. Lancet Infect Dis 2009; 9: 357-64.
19. Strahilevitz J, Jacoby GA, Hooper DC et al. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 2009; 22: 664-89.
20. Trzcinski K, Thompson CM, Gilbey AM et al. Incremental increase in fitness cost with increased β-lactam resistance in pneumococci evaluated by competition in an infant rat nasal colonisation model. J Infect Dis 2006; 193: 1296-303.
21. Lindgren PK, Marcusson LL, Sandvang D et al. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob Agents Chemother 2005; 49: 2343-51.
22. Enne VI, Bennett PM, Livermore DM et al. Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J Antimicrob Chemother 2004; 53: 1325-8.
23. Bouma JE, Lenski RE. Evolution of a bacteria/plasmid association. Nature 1988; 335: 351-2.
24. Dahlberg C, Chao L. Amelioration of the cost of conjugative plasmid carriage in Escherichia coli K12. Genetics 2003; 165: 1641-9.
25. McDermott PJ, Gowland P, Gowland PC. Adaptation of Escherichia coli growth rates to the presence of pBR322. Lett Appl Microbiol 1993; 17: 139-43.
26. Valenzuela MS, Ikpeazu EV, Siddiqui KAI. E. coli growth inhibition by a high copy number derivative of plasmid pBR322. Biochem Bioph Res Co 1996; 219: 876-83.
27. Enne VI, Delsol AA, Davis GR et al. Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element. J Antimicrob Chemother 2005; 56: 544-51.
28. Yates CM, Shaw DJ, Roe AJ et al. Enhancement of bacterial competitive fitness by apramycin resistance plasmids from non-pathogenic Escherichia coli. Biol Lett 2006; 2: 463-5.
29. Petersen A, Aarestrup FM, Olsen JE. The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions. FEMS Microbiol Lett 2009; 299:53-9.
30. Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol 2001; 9: 438-44.
31. Enne VI, Bennett PM. The fitness cost imposed by plasmid RP1 on Escherichia coli differs from strain to strain. Clin Microbiol Infect 2006; 12 Suppl S4: P1234.
32. Bidet P, Burghoffer B, Gautier V et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother 2005; 49: 3562-5.
33. Karami N, Martner A, Enne VI et al. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 2007; 60: 1137-41.
34. Trobos M, Lester CH, Olsen JE et al. Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine. J Antimicrob Chemother 2009; 63:80-6.